[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2018-2023 Global Extracorporeal Membrane Oxygenation (ECMO) Market Report (Status and Outlook)

August 2018 | 117 pages | ID: 2C0FCAD3B41EN
LP Information

US$ 4,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Extracorporeal Membrane Oxygenation (ECMO) market for 2018-2023.

ECMO is an extracorporeal technique of providing prolonged cardiac and respiratory support to persons whose heart and lungs are unable to provide an adequate amount of gas exchange or perfusion to sustain life
The major factors boosting growth are the rising incidences of Chronic Obstructive Pulmonary Disorder (COPD), and surging prevalence of cardiopulmonary diseases and respiratory failures.
Over the next five years, LPI(LP Information) projects that Extracorporeal Membrane Oxygenation (ECMO) will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares and growth opportunities of Extracorporeal Membrane Oxygenation (ECMO) market by product type, application, key companies and key regions.

To calculate the market size, LP Information considers value generated from the sales of the following segments:

Segmentation by product type:
  • Veno-Arterial
  • Arterio-Venous
Segmentation by application:
  • Respiratory
  • Cardiac
  • Extracorporeal Cardiopulmonary Resuscitation (ECPR)
We can also provide the customized separate regional or country-level reports, for the following regions:
  • Americas
  • United States
  • Canada
  • Mexico
  • Brazil
  • APAC
  • China
  • Japan
  • Korea
  • Southeast Asia
  • India
  • Australia
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
  • Spain
  • Middle East & Africa
  • Egypt
  • South Africa
  • Israel
  • Turkey
  • GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
  • MAQUET
  • Microport
  • XENIOS
  • LivaNova
  • Medtronic
  • Terumo Cardiovascular
  • Nipro
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
  • To study and analyze the global Extracorporeal Membrane Oxygenation (ECMO) market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
  • To understand the structure of Extracorporeal Membrane Oxygenation (ECMO) market by identifying its various subsegments.
  • Focuses on the key global Extracorporeal Membrane Oxygenation (ECMO) players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
  • To analyze the Extracorporeal Membrane Oxygenation (ECMO) with respect to individual growth trends, future prospects, and their contribution to the total market.
  • To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
  • To project the size of Extracorporeal Membrane Oxygenation (ECMO) submarkets, with respect to key regions (along with their respective key countries).
  • To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
  • To strategically profile the key players and comprehensively analyze their growth strategies.
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Extracorporeal Membrane Oxygenation (ECMO) Market Size 2013-2023
  2.1.2 Extracorporeal Membrane Oxygenation (ECMO) Market Size CAGR by Region
2.2 Extracorporeal Membrane Oxygenation (ECMO) Segment by Type
  2.2.1 Veno-Arterial
  2.2.2 Arterio-Venous
  2.2.3 Veno-Venous
2.3 Extracorporeal Membrane Oxygenation (ECMO) Market Size by Type
  2.3.1 Global Extracorporeal Membrane Oxygenation (ECMO) Market Size Market Share by Type (2013-2018)
  2.3.2 Global Extracorporeal Membrane Oxygenation (ECMO) Market Size Growth Rate by Type (2013-2018)
2.4 Extracorporeal Membrane Oxygenation (ECMO) Segment by Application
  2.4.1 Respiratory
  2.4.2 Cardiac
  2.4.3 Extracorporeal Cardiopulmonary Resuscitation (ECPR)
2.5 Extracorporeal Membrane Oxygenation (ECMO) Market Size by Application
  2.5.1 Global Extracorporeal Membrane Oxygenation (ECMO) Market Size Market Share by Application (2013-2018)
  2.5.2 Global Extracorporeal Membrane Oxygenation (ECMO) Market Size Growth Rate by Application (2013-2018)

3 GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO) BY PLAYERS

3.1 Global Extracorporeal Membrane Oxygenation (ECMO) Market Size Market Share by Players
  3.1.1 Global Extracorporeal Membrane Oxygenation (ECMO) Market Size by Players (2016-2018)
  3.1.2 Global Extracorporeal Membrane Oxygenation (ECMO) Market Size Market Share by Players (2016-2018)
3.2 Global Extracorporeal Membrane Oxygenation (ECMO) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO) BY REGIONS

4.1 Extracorporeal Membrane Oxygenation (ECMO) Market Size by Regions
4.2 Americas Extracorporeal Membrane Oxygenation (ECMO) Market Size Growth
4.3 APAC Extracorporeal Membrane Oxygenation (ECMO) Market Size Growth
4.4 Europe Extracorporeal Membrane Oxygenation (ECMO) Market Size Growth
4.5 Middle East & Africa Extracorporeal Membrane Oxygenation (ECMO) Market Size Growth

5 AMERICAS

5.1 Americas Extracorporeal Membrane Oxygenation (ECMO) Market Size by Countries
5.2 Americas Extracorporeal Membrane Oxygenation (ECMO) Market Size by Type
5.3 Americas Extracorporeal Membrane Oxygenation (ECMO) Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Extracorporeal Membrane Oxygenation (ECMO) Market Size by Countries
6.2 APAC Extracorporeal Membrane Oxygenation (ECMO) Market Size by Type
6.3 APAC Extracorporeal Membrane Oxygenation (ECMO) Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Extracorporeal Membrane Oxygenation (ECMO) by Countries
7.2 Europe Extracorporeal Membrane Oxygenation (ECMO) Market Size by Type
7.3 Europe Extracorporeal Membrane Oxygenation (ECMO) Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Extracorporeal Membrane Oxygenation (ECMO) by Countries
8.2 Middle East & Africa Extracorporeal Membrane Oxygenation (ECMO) Market Size by Type
8.3 Middle East & Africa Extracorporeal Membrane Oxygenation (ECMO) Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO) MARKET FORECAST

10.1 Global Extracorporeal Membrane Oxygenation (ECMO) Market Size Forecast (2018-2023)
10.2 Global Extracorporeal Membrane Oxygenation (ECMO) Forecast by Regions
  10.2.1 Global Extracorporeal Membrane Oxygenation (ECMO) Forecast by Regions (2018-2023)
  10.2.2 Americas Market Forecast
  10.2.3 APAC Market Forecast
  10.2.4 Europe Market Forecast
  10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
  10.3.1 United States Market Forecast
  10.3.2 Canada Market Forecast
  10.3.3 Mexico Market Forecast
  10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
  10.4.1 China Market Forecast
  10.4.2 Japan Market Forecast
  10.4.3 Korea Market Forecast
  10.4.4 Southeast Asia Market Forecast
  10.4.5 India Market Forecast
  10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
  10.5.1 Germany Market Forecast
  10.5.2 France Market Forecast
  10.5.3 UK Market Forecast
  10.5.4 Italy Market Forecast
  10.5.5 Russia Market Forecast
  10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
  10.6.1 Egypt Market Forecast
  10.6.2 South Africa Market Forecast
  10.6.3 Israel Market Forecast
  10.6.4 Turkey Market Forecast
  10.6.5 GCC Countries Market Forecast
10.7 Global Extracorporeal Membrane Oxygenation (ECMO) Forecast by Type
10.8 Global Extracorporeal Membrane Oxygenation (ECMO) Forecast by Application

11 KEY PLAYERS ANALYSIS

11.1 MAQUET
  11.1.1 Company Details
  11.1.2 Extracorporeal Membrane Oxygenation (ECMO) Product Offered
  11.1.3 MAQUET Extracorporeal Membrane Oxygenation (ECMO) Revenue, Gross Margin and Market Share (2016-2018)
  11.1.4 Main Business Overview
  11.1.5 MAQUET News
11.2 Microport
  11.2.1 Company Details
  11.2.2 Extracorporeal Membrane Oxygenation (ECMO) Product Offered
  11.2.3 Microport Extracorporeal Membrane Oxygenation (ECMO) Revenue, Gross Margin and Market Share (2016-2018)
  11.2.4 Main Business Overview
  11.2.5 Microport News
11.3 XENIOS
  11.3.1 Company Details
  11.3.2 Extracorporeal Membrane Oxygenation (ECMO) Product Offered
  11.3.3 XENIOS Extracorporeal Membrane Oxygenation (ECMO) Revenue, Gross Margin and Market Share (2016-2018)
  11.3.4 Main Business Overview
  11.3.5 XENIOS News
11.4 LivaNova
  11.4.1 Company Details
  11.4.2 Extracorporeal Membrane Oxygenation (ECMO) Product Offered
  11.4.3 LivaNova Extracorporeal Membrane Oxygenation (ECMO) Revenue, Gross Margin and Market Share (2016-2018)
  11.4.4 Main Business Overview
  11.4.5 LivaNova News
11.5 Medtronic
  11.5.1 Company Details
  11.5.2 Extracorporeal Membrane Oxygenation (ECMO) Product Offered
  11.5.3 Medtronic Extracorporeal Membrane Oxygenation (ECMO) Revenue, Gross Margin and Market Share (2016-2018)
  11.5.4 Main Business Overview
  11.5.5 Medtronic News
11.6 Terumo Cardiovascular
  11.6.1 Company Details
  11.6.2 Extracorporeal Membrane Oxygenation (ECMO) Product Offered
  11.6.3 Terumo Cardiovascular Extracorporeal Membrane Oxygenation (ECMO) Revenue, Gross Margin and Market Share (2016-2018)
  11.6.4 Main Business Overview
  11.6.5 Terumo Cardiovascular News
11.7 Nipro
  11.7.1 Company Details
  11.7.2 Extracorporeal Membrane Oxygenation (ECMO) Product Offered
  11.7.3 Nipro Extracorporeal Membrane Oxygenation (ECMO) Revenue, Gross Margin and Market Share (2016-2018)
  11.7.4 Main Business Overview
  11.7.5 Nipro News

...

12 RESEARCH FINDINGS AND CONCLUSION

LIST OF TABLES AND FIGURES

Table Product Specifications of Extracorporeal Membrane Oxygenation (ECMO)
Figure Extracorporeal Membrane Oxygenation (ECMO) Report Years Considered
Figure Market Research Methodology
Figure Glob


More Publications